The expression of some of these transporters is decreased in AD brain and/or transgenic mouse models of AD (ABCB1, ABCG1) while others are increased (ABCA7, ABCC1, ABCG4; conflicting reports for ABCG2). This evidence concerns the gene ABCG1 and Alzheimer disease.